Markets › India › NSE › LAURUSLABS

Laurus Labs Ltd

NSE:LAURUSLABSHealthcareNSE:CNX200NSE:CNX500

₹2,069.00+0.43%At closeAt close · Mon 19 Oct · ≈ AED 79.83 · Market cap $11.69B · Next earnings Thu 22 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	54.3%	54.4%	52.7%	49.6%	53.4%	40.2%	—	—
Operating margin	44.9%	43.6%	42.3%	35.8%	39.1%	19.0%	19.0%	+0.0 pts
Net margin	20.4%	16.8%	13.1%	3.2%	6.5%	13.0%	13.0%	+0.0 pts
EBITDA margin	32.2%	28.7%	26.6%	15.1%	18.6%	26.9%	—	—
Return on equity	37.9%	24.7%	19.6%	3.9%	8.0%	16.8%	16.4%	−0.4 pts
Return on assets	17.1%	11.9%	10.3%	1.9%	3.8%	8.5%	8.5%	+0.0 pts
Return on capital employed	65.6%	50.2%	48.9%	34.2%	37.5%	18.9%	—	—
Debt / equity	0.6×	0.5×	0.5×	0.6×	0.6×	0.5×	0.5×	−2.4%
Debt / assets	25.8%	25.5%	26.3%	30.7%	29.6%	24.0%	—	—
Interest coverage	32.5×	23.4×	17.9×	10.0×	10.2×	7.6×	—	—
Current ratio	1.3×	1.2×	1.4×	1.2×	1.2×	1.3×	1.3×	+0.0%
Quick ratio	0.6×	0.6×	0.7×	0.6×	0.7×	0.7×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	0.8×	0.7×	0.8×	0.6×	0.6×	0.6×	—	—
Inventory turnover	1.4×	1.3×	1.7×	1.4×	1.3×	1.7×	—	—
Receivables turnover	3.5×	3.5×	3.7×	3.0×	2.7×	3.2×	—	—
Dividend payout	7.6%	10.4%	13.6%	53.7%	12.0%	9.7%	—	—